Multiple Sclerosis and Chronic Fatigue

From a Western perspective, fatigue in multiple sclerosis is a prototypical multifactorial symptom with both central and secondary drivers. Central mechanisms include neuroinflammation, demyelination, axonal loss, impaired network efficiency, and autonomic and neuroendocrine changes that heighten effort perception and reduce cognitive/physical stamina. Simultaneously, secondary factors—sleep disorders (apnea, insomnia), mood disturbances, pain and spasticity, bladder dysfunction causing nocturia, medication side effects, deconditioning, and environmental heat—compound fatigue. Because these elements frequently coexist, effective management requires a systematic, layered plan. First, clinicians should screen for and treat reversible contributors: sleep studies for suspected apnea or restless legs; targeted labs for thyroid dysfunction and iron/B12 deficiency; review and rationalize sedating medications; screen and treat depression/anxiety; address pain and spasticity; and implement bladder strategies to reduce nocturia. Second, nonpharmacologic therapies form the backbone: individualized energy conservation and pacing; symptom-titrated aerobic and resistance exercise or physiotherapy (with attention to heat sensitivity); occupational therapy to optimize task efficiency; CBT to improve coping and reduce fatigue impact; and CBT for insomnia to consolidate sleep. Cooling strategies (vests, pre-cooling, temperature planning) can mitigate heat-related worsening. Pharmacologic options—amantadine first-line in many practices, with modafinil or methylphenidate considered case-by-case—are reasonable time-limited trials after nonpharmacologic foundations are in place, with continuation only if meaningful benefit emerges. Vitamin D repletion when deficient and smoking cessation support overall MS care. This integrated approach, anchored in regular reassessment and shared decision-making, offers the best chance to reduce fatigue severity and restore participation in daily life.

Eastern medicine frames MS-like conditions and chronic fatigue as disturbances in vital energy and systemic balance. In Traditional Chinese Medicine, patterns such as Spleen and Kidney Qi deficiency with Dampness/Phlegm can manifest as heaviness, weakness, and fatigability; MS aligns with ‘Wei syndrome’ (atrophy), where nourishing Qi and Blood and resolving Dampness are therapeutic priorities. Ayurveda views MS through Vata–Kapha imbalance with depletion of Ojas, impairing resilience and nervous system integrity. Therapeutic aims center on restoring vitality, calming the nervous system, and optimizing digestion and sleep. Low-risk, mind–body modalities—yoga, tai chi, and qigong—are supported by small trials showing improvements in fatigue and mood for people with MS. Acupuncture protocols that tonify and calm (e.g., ST36, SP6, KI3, GV20) are used clinically for fatigue; evidence specific to MS is limited but promising for subjective symptoms in some patients. Herbal tonics/adaptogens such as ginseng or astragalus (TCM) and ashwagandha (Ayurveda) are traditionally employed to enhance stamina; however, rigorous MS-specific data are sparse, and potential herb–drug interactions or immune effects necessitate clinician oversight. Dietary strategies—warm, easily digestible meals in TCM; Vata-pacifying, anti-inflammatory foods in Ayurveda—may indirectly reduce fatigue by supporting sleep, mood, and gastrointestinal function. Integrating these practices with evidence-based Western care, and tailoring intensity through pacing to avoid post-exertional symptom flares, can offer a comprehensive, person-centered fatigue management plan.